• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第一部分:毛霉菌病:患病率、危险因素、临床特征和诊断。

Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis.

机构信息

Division of Pulmonary, Critical Care Medicine, Allergy, and Clinical Immunology, Department of Internal Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

出版信息

Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(7):723-736. doi: 10.1080/14787210.2023.2220964. Epub 2023 Jun 7.

DOI:10.1080/14787210.2023.2220964
PMID:37262298
Abstract

INTRODUCTION

Mucormycosis (MCR) is caused by filamentous molds within the Class Zygomycetes and Order Mucorales. Infections can result from inhalation of spores into the nares, oropharynx, or lungs, ingestion of contaminated food or water, or inoculation into disrupted skin or wounds. In developed countries, MCR occurs primarily in severely immunocompromised hosts. In contrast, in developing/low income countries, most cases of MCR occur in persons with poorly controlled diabetes mellitus and some cases in immunocompetent subjects following trauma. Mucormycosis exhibits a propensity to invade blood vessels, leading to thrombosis and infarction of tissue. Mortality rates associated with invasive MCR are high and can exceed 90% with disseminated disease. Mucormycosis can be classified as one of six forms: (1) rhino-orbital-cerebral mucormycosis (ROCM); (2) pulmonary; (3) cutaneous; (4) gastrointestinal or renal (5); disseminated; or (6) uncommon (focal) sites.

AREAS COVERED

The authors discuss the prevalence, risk factors, and clinical features of mucormycosis. A literature search of mucormycosis was performed via PubMed (up to November 2022), using the key words: invasivefungal infections; mold; mucormycosis;Mucorales; Zyzomyces; Zygomycosis; Rhizopus, diagnosis.

EXPERT OPINION

Mucormycosis occurs primarily in severely immunocompromised hosts. Mucormycosis can progress rapidly, and delay in initiating treatment by even a few days worsens outcomes.

摘要

简介

毛霉病(MCR)由接合菌门毛霉目真菌引起。感染可源于孢子吸入鼻腔、口咽或肺部,摄入污染的食物或水,或接种于破损的皮肤或伤口。在发达国家,MCR 主要发生于严重免疫功能低下的宿主。相比之下,在发展中国家/低收入国家,大多数 MCR 病例发生于糖尿病控制不佳的患者,部分免疫功能正常的患者在创伤后也会发生。毛霉病易侵犯血管,导致血栓形成和组织梗死。侵袭性 MCR 相关死亡率高,播散性疾病的死亡率超过 90%。毛霉病可分为六种类型:(1)鼻-眶-脑毛霉病(ROCM);(2)肺部;(3)皮肤;(4)胃肠道或肾脏(5);播散性;或(6)不常见(局灶性)部位。

涵盖领域

作者讨论了毛霉病的流行率、危险因素和临床特征。通过 PubMed 进行了毛霉病的文献检索(截至 2022 年 11 月),使用的关键词为:侵袭性真菌感染;霉菌;毛霉病;毛霉目;毛霉属;接合菌病;根霉,诊断。

专家意见

毛霉病主要发生于严重免疫功能低下的宿主。毛霉病进展迅速,即使仅延迟几天开始治疗也会使预后恶化。

相似文献

1
Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis.第一部分:毛霉菌病:患病率、危险因素、临床特征和诊断。
Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(7):723-736. doi: 10.1080/14787210.2023.2220964. Epub 2023 Jun 7.
2
Mucormycosis.毛霉菌病。
Semin Respir Crit Care Med. 2020 Feb;41(1):99-114. doi: 10.1055/s-0039-3401992. Epub 2020 Jan 30.
3
Mucormycosis in 2023: an update on pathogenesis and management.2023 年的毛霉菌病:发病机制和治疗的最新进展。
Front Cell Infect Microbiol. 2023 Sep 21;13:1254919. doi: 10.3389/fcimb.2023.1254919. eCollection 2023.
4
Part 2: mucormycosis: focus on therapy.第二部分:毛霉病:重点关注治疗。
Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(7):737-748. doi: 10.1080/14787210.2023.2224564. Epub 2023 Jun 13.
5
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.打破常规:毛霉病及当前药物治疗选择综述
Ann Pharmacother. 2016 Sep;50(9):747-57. doi: 10.1177/1060028016655425. Epub 2016 Jun 15.
6
Zygomycetes in human disease.人类疾病中的接合菌纲真菌。
Clin Microbiol Rev. 2000 Apr;13(2):236-301. doi: 10.1128/CMR.13.2.236.
7
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes.非洲的毛霉菌病:流行病学、诊断和治疗结果。
Mycoses. 2023 Jul;66(7):555-562. doi: 10.1111/myc.13581. Epub 2023 Mar 7.
8
The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports.毛霉病的流行病学和临床表现:病例报告的系统评价和荟萃分析。
Clin Microbiol Infect. 2019 Jan;25(1):26-34. doi: 10.1016/j.cmi.2018.07.011. Epub 2018 Jul 21.
9
Managing mucormycosis in diabetic patients: A case report with critical review of the literature.糖尿病患者毛霉菌病的管理:病例报告并文献复习。
Oral Dis. 2022 Apr;28(3):568-576. doi: 10.1111/odi.13802. Epub 2021 Mar 2.
10
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment.毛霉病和虫霉病:临床表现、诊断与治疗综述
Clin Microbiol Infect. 2004 Mar;10 Suppl 1:31-47. doi: 10.1111/j.1470-9465.2004.00843.x.

引用本文的文献

1
Bronchial stent implantation in patient with bronchial obstruction caused by pulmonary mucormycosis: a case report.肺毛霉菌病致支气管阻塞患者的支气管支架植入术:一例报告
AME Case Rep. 2025 May 7;9:74. doi: 10.21037/acr-24-277. eCollection 2025.
2
Rhino-Orbital Mucormycosis With Delayed Diagnosis in an Immunocompromised Patient: A Case Report.免疫功能低下患者的鼻眶毛霉菌病伴诊断延迟:一例报告
Cureus. 2025 May 23;17(5):e84702. doi: 10.7759/cureus.84702. eCollection 2025 May.
3
Survival and prognostic factors in rhino-orbito-cerebral mucormycosis: A 3-year cohort study.
鼻眶脑型毛霉菌病的生存及预后因素:一项为期3年的队列研究。
Sci Rep. 2025 May 8;15(1):16088. doi: 10.1038/s41598-025-98926-9.
4
Intra-abdominal Mucormycosis in an Immunocompetent Host: A Rare Presentation and Literature Review.免疫功能正常宿主的腹腔毛霉菌病:一种罕见表现及文献综述
Cureus. 2025 Mar 17;17(3):e80730. doi: 10.7759/cureus.80730. eCollection 2025 Mar.
5
Chronic cutaneous and mucosal mucormycosis: as a major pathogenic fungus.慢性皮肤和黏膜毛霉病:作为一种主要的致病真菌。
Emerg Microbes Infect. 2025 Dec;14(1):2477653. doi: 10.1080/22221751.2025.2477653. Epub 2025 Mar 18.
6
Invasive splenic mucormycosis due to during chemotherapy for acute monocytic leukemia: a case report and literature review.急性单核细胞白血病化疗期间侵袭性脾脏毛霉病1例报告并文献复习
Front Oncol. 2023 Sep 8;13:1237807. doi: 10.3389/fonc.2023.1237807. eCollection 2023.